Mutations inactivating UTX are found across all stages of urothelial carcinoma (UC), albeit more commonly in lower stage tumors [11], and intriguingly, across all molecular subtypes of muscle-invasive bladder cancers (MIBC) [2]. This evidence concerns the gene KDM6A and urothelial carcinoma.